Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
06 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250606856150/en/Neurogene-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
17 May 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/neurogene-details-severe-aav-reaction-led-young-patients-death-rett-syndrome-gene-therapy
16 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250516891726/en/Neurogene-Announces-Evidence-Based-Monitoring-and-Treatment-Intended-to-Reverse-Rare-Hyperinflammatory-Syndrome-Associated-with-High-Dose-AAV
09 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250509094802/en/Neurogene-Reports-First-Quarter-2025-Financial-Results-and-Highlights-Recent-Updates
08 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250508808486/en/Neurogene-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
28 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250428733532/en/Neurogene-Announces-Upcoming-Oral-Presentation-on-Monitoring-and-Treatment-to-Reverse-Rare-Complication-of-High-Dose-Gene-Therapy-at-the-ASGCT-Annual-Meeting
ABOUT THIS PAGE